Home › Funds › D. E. Shaw & Co › EIGR

D. E. Shaw & Co position in EIGR

EIGER BIOPHARMACEUTICALS INC

Latest position (Q4 2022)46.50K sh
Reported value held$54.87K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q4 2021 28.97K $150.00K New
Q1 2022 336.05K $2.79M Add
Q2 2022 256.81K $1.62M Reduce
Q3 2022 102.20K $770.00K Reduce
Q4 2022 46.50K $54.87K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding EIGR

No other tracked fund reports a position in EIGR.

All EIGR fund holders →